Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Biologics Testing Market from 2024 to 2025?

The market size of biologics testing has seen a swift expansion in the last few years. It is projected to surge from $5.92 billion in 2024 to $6.85 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 15.7%. The significant growth experienced in the past can be linked to the development in biologics, rigorous regulatory frameworks, emphasis on quality management in bioprocessing, rising investment in biopharmaceuticals, and the increase in the capacity for biomanufacturing.

What Is the Projected Market Size of the Biologics Testing Market?

The market size of biologics testing is predicted to experience fast-paced growth in the forthcoming years, with projections estimating it to reach “$12.91 billion by the year 2029, expanding at a compound annual growth rate (CAGR) of 17.2%. This growth during the forecast period can be credited to the development of novel therapies, the surging demand for contract testing services, broadening of biologics pipelines, globalization of biopharmaceutical manufacturing, and a rising demand for quick testing solutions. The forecast period is also anticipated to witness significant trends such as advanced analytical technologies, reliance on cell-based assays, next-generation sequencing (NGS), application of quality by design (QBD) principles, and integration of artificial intelligence (AI), along with rapid methods for product release.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

Who are the Major Competitors in the Biologics Testing Market Outlook?

Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

What Is Fueling Growth in the Biologics Testing Market?

The swift expansion of the biotechnology and pharmaceutical sectors is anticipated to drive the growth of the biologics testing market. The primary concern of the pharmaceutical industry includes the creation and development of medicines for a wide range of diseases and health problems. On the flip side, the biotechnology sector is centered around the exploitation of technology in the fields of biology and healthcare. Biologic testing involves the examination needed to discern and quantify contaminants, test stability, and assess the drug’s immunological response. The escalating growth of the biotechnology and pharmaceutical industries has triggered advancements in biologics testing technology, such as the introduction of innovative analytical tools and techniques. This has facilitated more precise and effective testing, decreasing the cost and duration needed to introduce new biologics to the market. For example, as per Eurostat, a Belgian regulatory organization, the production of pharmaceuticals in the EU witnessed a rise from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, showcasing substantial growth in the sector. Hence, the swift escalating pharmaceutical and biotechnological sectors drive the growth of the biologics testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Which Biologics Testing Market Segments Are Growing the Fastest?

The biologics testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Other Products

2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits

2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments

3) By Other Products: Software, Consumables, Reference Standards

Which Industry Trends Are Shaping the Future of the Biologics Testing Market?

The trend of product innovation is gaining traction in the biologics testing market. To maintain their market standing, companies in this field are introducing novel, innovative products. Most notable is the launch of the Endosafe Nexus 200 in December 2022 by Charles River Laboratories International, Inc., a non-clinical contract research organization based in the US. This instrument is fully robotized, data integrity compliant, and serves as an advancement in Charles River’s line of products. The Nexus 200 employs Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and has the capacity to handle straightforward or intricate serial dilutions for water, in-process, and final product assessments. The system functions on Endosafe EndoScan-V version 6.1, allowing data to be transferred to a Laboratory Information Management System (LIMS) interface providing increased traceability, security, and data management via an integrated touchscreen.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Which Countries Are Leading the Biologics Testing Market?

North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276

This Report Delivers Insight On:

1. How big is the biologics testing market, and how is it changing globally?

2. Who are the major companies in the biologics testing market, and how are they performing?

3. What are the key opportunities and risks in the biologics testing market right now?

4. Which products or customer segments are growing the most in the biologics testing market?

5. What factors are helping or slowing down the growth of the biologics testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model